Sangamo Therapeutics Shares Outstanding 2006-2019 | SGMO

Sangamo Therapeutics shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Sangamo Therapeutics Annual Shares Outstanding
(Millions of Shares)
2018 97
2017 78
2016 71
2015 70
2014 67
2013 56
2012 53
2011 51
2010 45
2009 42
2008 41
2007 37
2006 33
2005 26
Sangamo Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 102
Q4 2018 97
Q3 2018 102
Q2 2018 97
Q1 2018 86
Q4 2017 78
Q3 2017 84
Q2 2017 73
Q1 2017 71
Q4 2016 71
Q3 2016 71
Q2 2016 70
Q1 2016 70
Q4 2015 70
Q3 2015 70
Q2 2015 70
Q1 2015 69
Q4 2014 67
Q3 2014 68
Q2 2014 68
Q1 2014 63
Q4 2013 56
Q3 2013 55
Q2 2013 54
Q1 2013 53
Q4 2012 53
Q3 2012 53
Q2 2012 53
Q1 2012 53
Q4 2011 51
Q3 2011 52
Q2 2011 52
Q1 2011 45
Q4 2010 45
Q3 2010 45
Q2 2010 45
Q1 2010 45
Q4 2009 42
Q3 2009 41
Q2 2009 41
Q1 2009 41
Q4 2008 41
Q3 2008 41
Q2 2008 41
Q1 2008 40
Q4 2007 37
Q3 2007 39
Q2 2007 35
Q1 2007 35
Q4 2006 33
Q3 2006 34
Q2 2006 31
Q1 2006 31
Q4 2005 26
Q3 2005 25
Q2 2005 25
Q1 2005 25
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.402B $0.084B
Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc., formerly known as Sangamo BioSciences Inc., is based in Richmond, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.508B 12.38
Gilead Sciences (GILD) United States $85.686B 10.40
Celgene (CELG) United States $64.115B 10.86
Vertex Pharmaceuticals (VRTX) United States $45.613B 55.14
Biogen (BIIB) United States $45.028B 8.55
Illumina (ILMN) United States $43.887B 50.86
CSL (CSLLY) Australia $36.043B 0.00
Regeneron Pharmaceuticals (REGN) United States $33.120B 15.57
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.639B 15.64
Incyte (INCY) United States $17.436B 70.70
Exact Sciences (EXAS) United States $15.096B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.897B 0.00
SINO PHARMACEUT (SBMFF) China $14.154B 0.00
Seattle Genetics (SGEN) United States $12.394B 0.00
Sarepta Therapeutics (SRPT) United States $11.244B 0.00
Genmab (GNMSF) Denmark $11.046B 56.15
Array BioPharma (ARRY) United States $10.373B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $8.989B 29.53
Galapagos (GLPG) Belgium $8.915B 0.00
Guardant Health (GH) United States $8.160B 0.00
Bio-Techne Corp (TECH) United States $8.121B 55.41
Alnylam Pharmaceuticals (ALNY) United States $8.085B 0.00
Bluebird Bio (BLUE) United States $7.786B 0.00
Exelixis (EXEL) United States $6.678B 17.02
Amarin (AMRN) Ireland $6.250B 0.00
BeiGene (BGNE) Cayman Islands $5.802B 0.00
Ascendis Pharma (ASND) Denmark $4.892B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.842B 0.00
Blueprint Medicines (BPMC) United States $4.799B 0.00
Moderna (MRNA) United States $4.692B 0.00
Horizon Pharma Public (HZNP) Ireland $4.554B 11.73
Repligen (RGEN) United States $4.146B 103.28
Mirati Therapeutics (MRTX) United States $3.817B 0.00
Alkermes (ALKS) Ireland $3.810B 0.00
Spark Therapeutics (ONCE) United States $3.771B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.770B 0.00
China Biologic Products (CBPO) China $3.686B 23.41
Ultragenyx Pharmaceutical (RARE) United States $3.590B 0.00
MorphoSys AG (MOR) Germany $3.514B 0.00
Arena Pharmaceuticals (ARNA) United States $3.071B 6.24
Amicus Therapeutics (FOLD) United States $3.053B 0.00
Immunomedics (IMMU) United States $2.931B 0.00
UniQure (QURE) Netherlands $2.819B 0.00
Medicines (MDCO) United States $2.740B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.631B 0.00
Reata Pharmaceuticals (RETA) United States $2.613B 0.00
MyoKardia (MYOK) United States $2.467B 0.00
Halozyme Therapeutics (HALO) United States $2.443B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.260B 0.00
Acceleron Pharma (XLRN) United States $2.260B 0.00
Ligand Pharmaceuticals (LGND) United States $2.259B 18.71
Emergent Biosolutions (EBS) United States $2.258B 19.61
NeoGenomics (NEO) United States $2.245B 147.00
Intercept Pharmaceuticals (ICPT) United States $2.135B 0.00
Zai Lab (ZLAB) China $2.087B 0.00
Genomic Health (GHDX) United States $2.083B 44.24
Akcea Therapeutics (AKCA) United States $2.047B 0.00
Denali Therapeutics (DNLI) United States $1.986B 0.00
Myriad Genetics (MYGN) United States $1.958B 19.47
REGENXBIO (RGNX) United States $1.826B 0.00
Insmed (INSM) United States $1.699B 0.00
Cambrex (CBM) United States $1.534B 19.40
Fate Therapeutics (FATE) United States $1.467B 0.00
RA PHARMCTL INC (RARX) United States $1.457B 0.00
AnaptysBio (ANAB) United States $1.432B 0.00
Innoviva (INVA) United States $1.368B 3.78
Athenex (ATNX) United States $1.307B 0.00
Alector (ALEC) United States $1.291B 0.00
Coherus BioSciences (CHRS) United States $1.254B 0.00
Editas Medicine (EDIT) United States $1.214B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.189B 0.00
Epizyme (EPZM) United States $1.161B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.078B 0.00
Codexis (CDXS) United States $1.028B 0.00
Cara Therapeutics (CARA) United States $1.007B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.001B 0.00
ANI Pharmaceuticals (ANIP) United States $0.976B 17.31
Twist Bioscience (TWST) United States $0.976B 0.00
Zymeworks (ZYME) Canada $0.960B 0.00
Principia Biopharma (PRNB) United States $0.957B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.911B 0.00
Retrophin (RTRX) United States $0.886B 0.00
Adverum Biotechnologies (ADVM) United States $0.878B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.844B 0.00
Vericel (VCEL) United States $0.841B 0.00
WAVE Life Sciences (WVE) Singapore $0.825B 0.00
Arvinas (ARVN) United States $0.791B 0.00
Intellia Therapeutics (NTLA) United States $0.787B 0.00
Precision BioSciences (DTIL) United States $0.746B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.705B 33.28
Zealand Pharma (ZEAL) Denmark $0.691B 8.07
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Intra-Cellular Therapies (ITCI) United States $0.649B 0.00
Cytokineticsorporated (CYTK) United States $0.648B 0.00
Cellectis S.A (CLLS) France $0.634B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.631B 0.00
Heska (HSKA) United States $0.626B 64.12
Clovis Oncology (CLVS) United States $0.613B 0.00
DBV Technologies S.A (DBVT) France $0.606B 0.00
Stemline Therapeutics (STML) United States $0.604B 0.00
Anika Therapeutics (ANIK) United States $0.584B 19.94
Lexicon Pharmaceuticals (LXRX) United States $0.566B 0.00
Revance Therapeutics (RVNC) United States $0.566B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.560B 0.00
CytomX Therapeutics (CTMX) United States $0.555B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
MiMedx (MDXG) United States $0.516B 0.00
Mesoblast (MESO) Australia $0.493B 0.00
UROGEN PHARMA (URGN) United States $0.447B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
PHARMA MAR SA (PHMMF) Spain $0.441B 0.00
Puma Biotechnology (PBYI) United States $0.407B 0.00
Prothena (PRTA) Ireland $0.399B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.17
Arcus Biosciences (RCUS) United States $0.380B 0.00
Biofrontera AG (BFRA) Germany $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
AC Immune SA (ACIU) Switzerland $0.370B 23.83
Gritstone Oncology (GRTS) United States $0.368B 0.00
Bellus Health (BLUSF) Canada $0.362B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.360B 0.00
Scholar Rock Holding (SRRK) United States $0.359B 0.00
Starpharma Holdings (SPHRY) Australia $0.355B 0.00
Avid Bioservices (CDMO) United States $0.351B 0.00
Albireo Pharma (ALBO) United States $0.350B 0.00
Merus (MRUS) Netherlands $0.341B 0.00
Agenus (AGEN) United States $0.340B 0.00
Kadmon Holdings (KDMN) United States $0.338B 0.00
BioDelivery Sciences (BDSI) United States $0.337B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.336B 0.00
Prometic Life Sciences (PFSCD) Canada $0.335B 0.00
Acorda Therapeutics (ACOR) United States $0.332B 5.84
Senesco Technologies (ELOX) United States $0.331B 0.00
Theratechnologies (THERF) Canada $0.331B 0.00
Syros Pharmaceuticals (SYRS) United States $0.321B 0.00
Sorrento Therapeutics (SRNE) United States $0.316B 0.00
Protagonist Therapeutics (PTGX) United States $0.311B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.304B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Inovio Pharmaceuticals (INO) United States $0.282B 0.00
Kindred Biosciences (KIN) United States $0.262B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.258B 0.00
Sutro Biopharma (STRO) United States $0.256B 0.00
PHASEBIO PHARMA (PHAS) United States $0.254B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.245B 0.00
Kamada (KMDA) Israel $0.240B 9.33
Dynavax Technologies (DVAX) United States $0.238B 0.00
Geron (GERN) United States $0.233B 0.00
ADMA Biologics Inc (ADMA) United States $0.224B 0.00
Athersys (ATHX) United States $0.223B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.222B 0.00
CorMedix Inc (CRMD) United States $0.215B 0.00
Palatin Technologies (PTN) United States $0.214B 0.00
Cel-Sci (CVM) United States $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Five Prime Therapeutics (FPRX) United States $0.202B 0.00
MannKind (MNKD) United States $0.201B 0.00
Cerecor (CERC) United States $0.198B 0.00
Affimed (AFMD) Germany $0.197B 0.00
Abeona Therapeutics (ABEO) United States $0.189B 0.00
Pfenex (PFNX) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.187B 0.00
Mersana Therapeutics (MRSN) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
Synlogic (SYBX) United States $0.183B 0.00
Arsanis (XFOR) United States $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.179B 0.00
Enzo Biochem (ENZ) United States $0.178B 0.00
Compugen (CGEN) Israel $0.174B 0.00
BioTime (BTX) United States $0.171B 11.40
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.162B 0.00
XOMA (XOMA) United States $0.161B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.156B 0.00
Cue Biopharma (CUE) United States $0.154B 0.00
Strongbridge Biopharma (SBBP) United States $0.153B 8.81
Liquidia Technologies (LQDA) United States $0.144B 0.00
OvaScience (MLND) United States $0.143B 0.00
Adocia (ADOCY) France $0.140B 0.00
TOCAGEN INC (TOCA) United States $0.140B 0.00
Celyad SA (CYAD) Belgium $0.139B 0.00
Dyadic (DYAI) United States $0.136B 0.00
Northwest Biotherapeutics (NWBO) United States $0.129B 0.00
Seres Therapeutics (MCRB) United States $0.129B 0.00
Aptinyx (APTX) United States $0.127B 0.00
Alcobra (ARCT) United States $0.125B 0.00
NantKwest (NK) United States $0.124B 0.00
Aduro Biotech (ADRO) United States $0.118B 0.00
Verastem (VSTM) United States $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.116B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Arbutus Biopharma (ABUS) Canada $0.111B 0.00
Novavax (NVAX) United States $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.105B 0.00
Menlo Therapeutics (MNLO) United States $0.104B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.103B 0.00
Checkpoint Therapeutics (CKPT) United States $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.101B 0.00
SESEN BIO, INC (SESN) United States $0.098B 0.00
Trevena (TRVN) United States $0.094B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.091B 0.00
Pluristem Therapeutics (PSTI) Israel $0.087B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.084B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.083B 0.00
Fortress Biotech (FBIO) United States $0.082B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.080B 0.00
Unum Therapeutics (UMRX) United States $0.080B 0.00
Selecta Biosciences (SELB) United States $0.077B 0.00
AquaBounty Technologies (AQB) United States $0.076B 0.00
Curis (CRIS) United States $0.075B 0.00
VBI Vaccines (VBIV) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
VTv Therapeutics (VTVT) United States $0.071B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 38.80
Oncobiologics (OTLK) United States $0.069B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.061B 0.00
Antibe Therapeutics (ATBPF) Canada $0.060B 0.00
ARAVIVE, INC (ARAV) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Protalix BioTherapeutics (PLX) Israel $0.057B 0.00
Invo BioScience (IVOB) United States $0.053B 0.00